TrialBMC cancer2014

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.

Peter A Fasching et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.